Stevia extract takes step toward EU acceptance
This article was originally published in The Tan Sheet
Executive SummarySteviol glycosides are neither genotoxic nor carcinogenic at an acceptable daily intake of 4 mg per kg of body weight daily, according to the European Food Safety Authority's scientific panel on additives. EFSA will submit its evaluation to the European Commission for consideration of whether the stevia extracts are safe to add to foods and beverages, the authority said April 14. In a same-day release, Truvia maker Cargill called the EFSA decision "a very important milestone in the path of European regulatory approval of steviol glycosides." EFSA's ADI determination for steviol glycosides is in line with that reached by the Joint Expert Committee on Food Additives of the World Health Organization and United Nations in 2008 (1"The Tan Sheet" Nov. 3, 2008)
You may also be interested in...
The company's decision to exit diabetes research is not necessarily surprising given the development and commercial challenges in the therapeutic area, but it's not insignificant either.
The global insulin pump market is expected to see significant growth, reaching $5.1bn by 2023. A new Market Intel story looks at the competitive landscape of the three leading companies in this market, Medtronic, Insulet and Tandem Diabetes Care, which are all expected to launch new products in 2020. See what Viral Shah, an assistant professor of medicine and pediatrics at the University of Colorado, said about the diabetes market here.